Vera P. Krymskaya, PhD, MBA, FCPP, Perelman School of Medicine, Chair
Dr. Vera Krymskaya is a Professor of Medicine with tenure at the University of Pennsylvania Perelman School of Medicine, in the Pulmonary, Allergy & Critical Care Division and the Penn Center for Pulmonary Biology. Dr. Krymskaya specializes in rare and common lung diseases including lymphangioleiomyomatosis (LAM), Tuberous Sclerosis (TS), Birt-Hogg-Dube, idiopathic Multicentric Castleman’s disease, pulmonary arterial hypertension, chronic obstructive pulmonary disease, and asthma. The focus of her studies is on determining molecular targets for potential therapeutic interventions. Dr. Krymskaya’s seminal discoveries in LAM and TS impacted the field's understanding of molecular mechanisms and the development of new DFA-approved clinical treatment for LAM and TS. She is Principal Investigator of a clinical trial to determine the safety of simvastatin (The SOS Trial) in combination with either sirolimus or everolimus in patients with LAM and TS-LAM.
Dr. Krymskaya received numerous awards including the Established Investigator Awards from the LAM Foundation, continued funding from the NIH NHLBI, DOD, and American Lung Association. Dr. Krymskaya serves on the Scientific Advisory Board of the LAM Foundation, National Disease Research Interchange, and the Castleman’s Disease Collaborative Network. She is a member of the Department of Defense TSC Research Program Scientific Peer Review Council. Dr. Krymskaya serves at the editorial board of the American Journal of Respiratory Cell and Molecular Biology and as a reviewer of many reputed journals including the Journal of Clinical Investigations, Cancer Research, and PNAS, among others. Dr. Krymskaya received the Science Advancement Award from the LAM Foundation, and is an elected fellow of the College of Physicians of Philadelphia.
Dr. Krymskaya has been a member of PFWF since 2012. She currently serves as Chair of the Penn Forum for Women Faculty.